Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $9.4115, but opened at $8.49. Aspen Pharmacare shares last traded at $8.49, with a volume of 1,010 shares changing hands.
Aspen Pharmacare Stock Performance
The business has a 50 day moving average of $9.08 and a 200-day moving average of $8.59. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.66 and a current ratio of 3.64.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Recommended Stories
- Five stocks we like better than Aspen Pharmacare
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
